Resmed (RMD) Equity Income (2018 - 2026)
Resmed (RMD) reported Equity Income of $2.23 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 76.0% from $1.27 million a year earlier and up 30.0% from the prior quarter.
Powered by 
Analysis
Resmed (RMD) Equity Income (2018 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Resmed posted Equity Income of $6.96 million, up 90.9% from FY2025.
- By fiscal year, Equity Income came in at $3.64 million in FY2025, -$1.85 million in FY2024, -$7.27 million in FY2023 and -$8.49 million in FY2022.
- The fiscal Q4 2026 figure ranks as the highest quarterly Equity Income in data going back to fiscal Q2 2019.
- Year over year, Equity Income has now increased in each of the last five quarters, with growth averaging 93.2% over the last seven quarters.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $1.72 million (Q3 2026), $1.52 million (Q2 2026) and $1.49 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | -15.00 Mn |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | - |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | - |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | - |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | - |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | - |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | - |
| 10 | Resmed | 35.85 Bn | 29.92 Bn | 861.22 Mn | 2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 335,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 963,000.00 |
| Jun 30, 2024 | 868,000.00 |
| Mar 31, 2024 | 440,000.00 |
| Dec 31, 2023 | 739,000.00 |
| Sep 30, 2023 | -3.90 Mn |
| Jun 30, 2023 | -2.23 Mn |
| Mar 31, 2023 | -183,000.00 |
| Dec 31, 2022 | -2.83 Mn |
| Sep 30, 2022 | -2.03 Mn |
| Jun 30, 2022 | -2.56 Mn |
| Mar 31, 2022 | -2.63 Mn |
| Dec 31, 2021 | -1.91 Mn |
| Sep 30, 2021 | -1.39 Mn |
API Access
Resmed Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();